Carisma Therapeutics, Inc. (CARM)
Carisma Therapeutics Market Cap: 1.777M for Jan. 9, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| NovaBay Pharmaceuticals, Inc. | 2.414B |
| Palatin Technologies, Inc. | 14.42M |
| Theriva Biologics, Inc. | 7.247M |
| Oragenics, Inc. | 0.6839M |
| NanoViricides, Inc. | 20.16M |
Market Cap Related Metrics
| PE Ratio | 0.2257 |
| PS Ratio | 0.0337 |
| Price | 0.0425 |
| Earnings Yield | 443.0% |
| Operating PE Ratio | 0.1637 |
| Normalized PE Ratio | 0.2085 |